Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin
about
Tris(benzimidazolyl)amine-Cu(II) coordination units bridged by carboxylates: structures and DNA-condensing property.The inhibitory role of Mir-29 in growth of breast cancer cellsEffects of long and short carboxylated or aminated multiwalled carbon nanotubes on blood coagulation.Repositioning antimicrobial agent pentamidine as a disruptor of the lateral interactions of transmembrane domain 5 of EBV latent membrane protein 1.A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity.Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2.Validated LC-MS/MS method for simultaneous determination of doxorubicin and curcumin in polymeric micelles in subcellular compartments of MCF-7/Adr cells by protein precipitation-ultrasonic breaking method.An Efficient Method for Electroporation of Small Interfering RNAs into ENCODE Project Tier 1 GM12878 and K562 Cell Lines.Quantitative trait locus linkage analysis in a large Amish pedigree identifies novel candidate loci for erythrocyte traits.Expression of cyclin A, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin.Detection of a prognostic indicator in early-stage cancer using functionalized graphene-based peptide sensors.Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer's disease treatment.Reduced graphene oxide upconversion nanoparticle hybrid for electrochemiluminescent sensing of a prognostic indicator in early-stage cancer.Selective and quantitative cancer cell detection using target-directed functionalized graphene and its synergetic peroxidase-like activity.
P2860
Q34052028-F208211A-CACD-43C0-B2B4-5189761409BCQ34249355-73CA2F29-3130-4D93-8B03-9B08424B36D3Q34341520-DA6BA55A-A2C2-4CDB-BD71-CFB0F27FA97DQ34456483-F739EF65-5831-4569-B03A-886DD1CAE844Q35681896-ED5032CF-4CCB-4044-8C5A-16D970BEA7D5Q35971810-1602CCBC-17C6-4793-822D-E4D2835AFAD7Q36197851-036229F6-7DAD-4F9A-9437-65509A255B37Q36232703-4542650C-B88D-49FC-99F0-E7A4E59DB151Q37177909-CEDCEB00-C80C-4387-B014-423B2657ECA5Q39285153-9F7FDF32-8A46-47A7-BBF3-B8D8F81A6330Q39433239-788DDF13-CFD9-463C-89CA-D51A0FA18849Q39513747-B8DA3453-8260-45B2-87E6-F0CA4FBDD560Q44315712-01CA93B5-D803-4E4A-B1EE-A994D4F0C28EQ53262267-00F7905F-03A1-47DC-948A-85AA3F30A04D
P2860
Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Knocking-down cyclin A(2) by s ...... dministration with doxorubicin
@ast
Knocking-down cyclin A(2) by s ...... dministration with doxorubicin
@en
type
label
Knocking-down cyclin A(2) by s ...... dministration with doxorubicin
@ast
Knocking-down cyclin A(2) by s ...... dministration with doxorubicin
@en
prefLabel
Knocking-down cyclin A(2) by s ...... dministration with doxorubicin
@ast
Knocking-down cyclin A(2) by s ...... dministration with doxorubicin
@en
P2093
P2860
P1433
P1476
Knocking-down cyclin A(2) by s ...... dministration with doxorubicin
@en
P2093
Jinsong Ren
Xiaogang Qu
Yujun Song
P2860
P356
10.1371/JOURNAL.PONE.0006665
P407
P50
P577
2009-08-17T00:00:00Z